James R. Edgerton

Medical City Dallas Hospital

Papers

1

Total Citations

74

H-Index

1

About

Dr. James R. Edgerton is a pioneering cardiothoracic surgeon whose work has fundamentally shaped the landscape of minimally invasive cardiac surgery. His primary research focus lies in the development and clinical validation of robotically-assisted coronary artery bypass grafting (CABG), a field in which he is considered a leading authority. Dr. Edgerton’s most impactful contribution is his leadership of the first prospective, multicenter clinical trial evaluating robotic CABG, a landmark study published in 2001 that has garnered 74 citations. This seminal work provided crucial evidence for the safety and feasibility of robotic techniques, helping to transition coronary revascularization from traditional open-heart procedures toward less invasive approaches. Beyond this foundational trial, his career is distinguished by a sustained commitment to refining surgical robotics and advancing patient outcomes through reduced trauma and faster recovery. Dr. Edgerton’s work has not only influenced surgical practice worldwide but has also inspired a generation of surgeons to embrace technological innovation in the operating room.

Research Focus

Key Achievements

1
H-Index
1
Papers
74
Total Citations
74
Avg Citations/Paper
🏆 Most Cited Paper
Initial prospective multicenter clinical trial of robotically-assisted coronary artery bypass grafting
74 citations · 2001
📈 Most Prolific Year: 2001 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Medical City Dallas Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago